Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06836830

PEEP vs. ZEEP in Out-of-Hospital-Cardiac-Arrest

Peri-Arrest Ventilation With Positive End-Expiratory-Pressure vs. Zero End-Expiratory-Pressure in Out-of-Hospital-Cardiac-Arrest

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
600 (estimated)
Sponsor
Muehlenkreiskliniken, MKK · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Out-of-hospital cardiac arrest (OHCA) remains a major cause of mortality, with low survival probabilities to hospital discharge. Despite the frequent use of airway management and mechanical ventilation during resuscitation, there is limited evidence regarding the optimal ventilation strategy to improve oxygen delivery and patient outcomes. The present study aims to investigate the effects of positive-end-expiratory-pressure (PEEP) set at 5 mbar compared to zero-end-expiratory-pressure (ZEEP) on the return of spontaneous-circulation (ROSC) in adult patients with OHCA.

Detailed description

This is a prospective, multicenter, cluster-randomized controlled trial conducted across emergency medical services (EMS) in the regions of Guetersloh, Minden-Luebbecke and Osnabrueck. Adult patients (\>= 18 years) with OHCA who are undergoing mechanical ventilation through an airway device will be enrolled. The clusters (regional district) will be randomized into two groups: one group will receive ventilation with PEEP set at 5 mbar (intervention group), while the other group will receive ventilation with ZEEP (control group). The study's primary endpoint is the rate of ROSC. Secondary endpoints include rate of re-arrest, death during pre-hospital care phase, hospital admission during ongoing resuscitation, hospital admission with spontaneous circulation, peripheral oxygen saturation and end tidal CO2 at hospital admission.

Conditions

Interventions

TypeNameDescription
PROCEDUREPEEP 5 mbarPositiv-End-Expiratory Pressure
PROCEDUREZEEP 0 mbarZero-End-Expiratory Pressure

Timeline

Start date
2025-06-01
Primary completion
2026-06-30
Completion
2026-10-31
First posted
2025-02-20
Last updated
2025-08-06

Locations

3 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT06836830. Inclusion in this directory is not an endorsement.